Clinical Trial Update: A Study in Male and Female Adult Patients With Atopic Dermatitis Treated With Dupilumab in Taiwan

View source ↗

Summary

This is a completed clinical trial evaluating dupilumab in adult patients with atopic dermatitis in Taiwan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• DUPIXENT (DUPILUMAB)

Snippet

Sponsor: Sanofi | Conditions: Atopic Dermatitis | Status: COMPLETED